首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Effect of intravenous saline, albumin, or hydroxyethylstarch on blood volume during combined ultrafiltration and hemodialysis.
【24h】

Effect of intravenous saline, albumin, or hydroxyethylstarch on blood volume during combined ultrafiltration and hemodialysis.

机译:在联合超滤和血液透析期间,静脉注射生理盐水,白蛋白或羟乙基淀粉对血容量的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

It is generally advocated to use saline or albumin infusions during symptomatic hypotension during dialysis. However, because of their side effects and/or costs, they are of limited use. Hydroxyethylstarch (HES), a synthetic colloid with a long-standing volume effect, is used in the management of hypovolemia. In this study, the efficacy of three fluids (isotonic saline [0.9%], albumin [20%], and HES [10%]) was assessed during three treatment sessions with combined ultrafiltration and hemodialysis, which differed in the type of fluid given intravenously. Changes in relative blood volume (BV), systolic BP (SBP), and vascular reactivity (venous tone [VT]) were compared. An intravenous infusion of 100 ml of fluid was given when the decrease in BV versus baseline was more than 10% as measured by a continuous optical reflection method. The ultrafiltration was continued. BV decreased significantly versus baseline independent of the intravenous fluid administration in all three treatment sessions. However, when we compared BV values at the end of the dialysis session with those at the time of infusion, BV continued to decrease significantly with saline (change in BV -4.56 +/- 2.75%; P < 0.05) and albumin (change in BV -2.13 +/- 2.51%; P < 0.05), but not with HES (change in BV -0.15 +/- 2.17%; NS). Between albumin and HES there were no significant differences in changes in BV (NS), whereas between HES and saline (P < 0.05) and between albumin and saline (P < 0.05) the differences in BV changes were significant. SBP remained unchanged within each session. Although SBP tended to decrease more with saline compared to albumin and HES, the difference was not significant. The higher decrease in BV and SBP with saline was counterbalanced by a significantly higher increase in VT, while VT remained unchanged in the other two sessions. It is concluded that HES is a promising fluid in preserving blood volume, comparable to albumin, but superior to saline.
机译:通常提倡在透析期间出现症状性低血压时使用生理盐水或白蛋白输注。但是,由于它们的副作用和/或成本,它们的使用受到限制。羟乙基淀粉(HES)是一种具有长效作用的合成胶体,可用于血容量不足的管理。在这项研究中,在超滤和血液透析联合治疗的三个治疗阶段中,评估了三种液体(等渗盐水[0.9%],白蛋白[20%]和HES [10%])的疗效,这两种液体的类型有所不同静脉注射。比较了相对血容量(BV),收缩压(SBP)和血管反应性(静脉张力[VT])的变化。当BV相对于基线的降低幅度超过10%(通过连续光学反射法测量)时,静脉输注100 ml液体。继续超滤。在所有三个疗程中,BV与基线相比均显着下降,而与静脉内输液无关。但是,当我们将透析结束时的BV值与输液时的BV值进行比较时,盐水(BV的变化为-4.56 +/- 2.75%; P <0.05)和白蛋白(BV的变化)继续显着降低。 BV -2.13 +/- 2.51%; P <0.05),但没有使用HES(BV -0.15 +/- 2.17%; NS)。白蛋白和HES之间的BV(NS)变化无显着差异,而HES和生理盐水之间(P <0.05)以及白蛋白和生理盐水之间(P <0.05)BV变化差异显着。每次会议期间SBP均保持不变。尽管与白蛋白和HES相比,盐水使SBP降低更多,但差异不显着。生理盐水中BV和SBP的较高下降被VT的明显较高抵消,而VT在其他两个疗程中保持不变。结论是,HES是保留血液量的有希望的液体,与白蛋白相当,但优于生理盐水。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号